LYN and breast carcinoma: In breast cancer, LYN has been reported as overexpressed and a potential drug target in TNBC by several studies (Choi et al., 2010, Hochgräfe et al., 2010, Molyneux et al., 2010, Regan et al., 2012, Smart et al., 2011).